A novel project for Chagas disease diagnosis and treatment has started in Spain. With the participation of Group Praxis, through its company Praxis Biopharma, Biokilab and CSICInstituto

 

de Parasitología y Biomedicina López – Neyra, the project aims in obtaining innovative diagnosis tools to get better diagnosis of CD, especially in terms of discrimination of different phases of the disease, and to establish the effectiveness of treatments. The project will also look for a therapeutic vaccine based on immune-dominant peptides.